Immunotherapy in non-small cell lung cancer harbouring driver mutations
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference114 articles.
1. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin Proc,2008
2. Outcome of patients with a performance status of 2 in eastern cooperative oncology group study E1594: a phase III trial in patients with metastatic nonsmall cell lung carcinoma;Sweeney;Can: Interdiscipl Int J Am Can Soc,2001
3. Advances in the development of molecularly targeted agents in non-small-cell lung cancer;Dolly;Drugs,2017
4. Chemotherapy in combination with immune checkpoint inhibitors for the first-line treatment of patients with advanced non-small cell lung cancer: a systematic review and literature-based meta-analysis;Addeo;Front Oncol,2019
5. Immune Checkpoint inhibitors: An introduction to the next-generation cancer immunotherapy;Lee;J Clin Pharmacol,2016
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rapid Advances in Resectable Non–Small Cell Lung Cancer;JAMA Oncology;2023-12-28
2. Unraveling the nexus: oncogenic drivers and immunotherapy efficacy in cancer treatment;Immunotherapy;2023-12-19
3. Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Lung Cancer: An Italian Expert Panel Discussion;Current Oncology;2023-11-20
4. Bringing immune-checkpoint inhibitors earlier in the management of non-small cell lung cancer;Translational Lung Cancer Research;2023-11
5. Novel targets for immune-checkpoint inhibition in cancer;Cancer Treatment Reviews;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前全球学者库共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3